Satish Bapusaheb Kulkarni
About Satish Bapusaheb Kulkarni
Data last updated:
Satish Bapusaheb Kulkarni is a Director at Fresenius Kabi India Private Limited (since 2012). The companies operate in Pharma and Healthcare. Fresenius Kabi India Private Limited reported revenue of ₹934 Cr (FY 2025). Earlier, Satish Bapusaheb Kulkarni was an Alternate Director at Fresenius Kabi Oncology Limited (2008–2013) and Additional Director at Fenwal India Private Limited (2012–2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fresenius Kabi India Private Limited U24231PN1995PTC014017 | Director | 01 Aug 2012 | 1995 | ₹934 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fresenius Kabi Oncology Limited U24231DL2003PLC119441 | Alternate Director | 11 Aug 2008 | 2003 | ₹848 Cr (FY 2025) | Active |
 Fenwal India Private Limited U24305HR2007PTC040846 | Additional Director | 14 Dec 2012 | 2007 | ₹10.6 Lakh (FY 2019) | Dissolved Under Section 59(8) |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satish Bapusaheb Kulkarni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hanno Michael Diehl | 08467115 | Fresenius Kabi India Private Limited | Director |
| Kaushal Devendra Gupta | Fresenius Kabi India Private Limited | Cfo | |
| Kaushal Devendra Gupta | 03267300 | Fresenius Kabi India Private Limited | Whole-Time Director |
| Prakash Sahebrao Patil | 09447619 | Fresenius Kabi India Private Limited | Director |
| Sanjay Kumar Gupta | 02295921 | Fresenius Kabi India Private Limited | Managing Director |
| Sayali Devadatta Shrotri | Fresenius Kabi India Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satish Bapusaheb Kulkarni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satish Bapusaheb Kulkarni
Satish Bapusaheb Kulkarni currently holds 1 directorship: Fresenius Kabi India Private Limited (Director, since 01 Aug 2012, revenue ₹934 Cr (FY 2025)).
Satish Bapusaheb Kulkarni was first appointed on 11 Aug 2008 as Alternate Director at Fresenius Kabi Oncology Limited. The most recent appointment on record is 14 Dec 2012 at Fenwal India Private Limited.
Satish Bapusaheb Kulkarni held 2 earlier board appointments: Fresenius Kabi Oncology Limited (Alternate Director, 11 Aug 2008 to 13 Feb 2013); Fenwal India Private Limited (Additional Director, 14 Dec 2012 to 31 Mar 2013).
The current boards of Satish Bapusaheb Kulkarni's companies include Hanno Michael Diehl (Fresenius Kabi India Private Limited), Kaushal Devendra Gupta (Fresenius Kabi India Private Limited), Kaushal Devendra Gupta (Fresenius Kabi India Private Limited), Prakash Sahebrao Patil (Fresenius Kabi India Private Limited), Sanjay Kumar Gupta (Fresenius Kabi India Private Limited), Sayali Devadatta Shrotri (Fresenius Kabi India Private Limited).